Table 2.
Clinical response after treatment with NOP vs. Glucantime
| Visit 1 (Day 20) | Visit 2 (Day 45) | Visit 3 (Day 90) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Glu* (N = 80) | NOP (N = 78) | P | Glu* (N = 78) | NOP (N = 69) | P | Glu* (N = 77) | NOP (N = 66) | P | |
| Complete clinical response n (%) | 55 (68.7) | 20 (25.6) | 0.0001 | 75 (96.1) | 24 (34.8) | 0.0001 | 73 (94.8) | 25 (37.8) | 0.0001 |
| Therapeutic failure n (%) | 0 | 29 (37.2) | 0.0001 | 0 (0) | 36 (52.2) | 0.0001 | 4 (5.2) | 41 (62.1) | 0.0001 |
| Clinical improvement n (%) | 13 (16.3) | 10 (12.8) | 0.66 | 3 (3.8) | 7 (10.1) | 0.14 | – | – | – |
| No response n (%) | 12 (15) | 18 (23.1) | 0.19 | 0 | 2 (4.8) | 0.06 | – | – | – |
*
Glucantime.